EP3038652
COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
28.8.2014:
21.3.2018:
14766301.7
:
27.8.2034
:
COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
28.8.2014
21.3.2018
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
HARRIS, Jennifer Leslie:
San Diego, California, US
:
LI, Nanxin:
San Diego, California, US
:
SMITH, Timothy R.:
San Diego, California, US
:
201361871275 P:
28.8.2013:
US
:
US2014053244:
28.8.2014
:
A61K 31/506, A61K 31/519, A61K 45/06, A61P 35/00